These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3899458)
21. [Industrial drug-surveillance]. Juillet Y Rev Med Interne; 1986 Nov; Spec No():29-34. PubMed ID: 3809777 [TBL] [Abstract][Full Text] [Related]
22. Adverse drug reaction reporting. Bosco LA Am J Gastroenterol; 1987 Apr; 82(4):356-7. PubMed ID: 3565343 [No Abstract] [Full Text] [Related]
23. Adverse drug reactions. Turner P Hum Toxicol; 1986 May; 5(3):161-2. PubMed ID: 3710492 [No Abstract] [Full Text] [Related]
24. Postmarketing studies of drug efficacy. Strom BL; Melmon KL; Miettinen OS Arch Intern Med; 1985 Oct; 145(10):1791-4. PubMed ID: 3899034 [No Abstract] [Full Text] [Related]
25. [Necessity and difficulties of quantitative drug monitoring]. Lagier G; Dally S; Vincens M; Castot A Therapie; 1983; 38(3):319-23. PubMed ID: 6612668 [No Abstract] [Full Text] [Related]
26. [Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid]. Lagier G; Vincens M; Castot A Therapie; 1983; 38(3):303-18. PubMed ID: 6612667 [No Abstract] [Full Text] [Related]
27. [Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods]. Lagier G; Vincens M; Lefebure B; Frelon JH Therapie; 1983; 38(3):295-302. PubMed ID: 6612666 [No Abstract] [Full Text] [Related]
28. Critical reflection on the collection and evaluation of adverse drug reaction data. Venulet J Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S48-53. PubMed ID: 3842691 [No Abstract] [Full Text] [Related]
29. Adverse reactions to new drugs. Venning GR Br Med J (Clin Res Ed); 1983 Mar; 286(6370):1052-3. PubMed ID: 6403183 [No Abstract] [Full Text] [Related]
31. [Drug surveillance throughout the world]. Venulet J Rev Med Interne; 1986 Nov; Spec No():52-6. PubMed ID: 3809781 [TBL] [Abstract][Full Text] [Related]
32. Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methods. Rossi AC; Knapp DE; Anello C; O'Neill RT; Graham CF; Mendelis PS; Stanley GR JAMA; 1983 Apr 22-29; 249(16):2226-28. PubMed ID: 6834622 [No Abstract] [Full Text] [Related]
33. The diagnosis of adverse medical events associated with drug treatment. Stephens MD Adverse Drug React Acute Poisoning Rev; 1987; 6(1):1-35. PubMed ID: 3303863 [No Abstract] [Full Text] [Related]
34. The desire to regulate: the wish to discover. Lasagna L Drugs Exp Clin Res; 1987; 13(11):659-64. PubMed ID: 3443041 [TBL] [Abstract][Full Text] [Related]
35. Biological indicator test packs: a survey of user practices. Smith DE J Healthc Mater Manage; 1988; 6(4):38, 40-2. PubMed ID: 10287653 [No Abstract] [Full Text] [Related]
36. Drug utilization data in benefit analysis of drugs. Liljestrand A Acta Med Scand Suppl; 1984; 683():135-9. PubMed ID: 6204508 [TBL] [Abstract][Full Text] [Related]
37. [Presentation of data in drug surveillance and bases for a decision]. Lagier G Rev Med Interne; 1986 Nov; Spec No():41-4. PubMed ID: 3809779 [TBL] [Abstract][Full Text] [Related]
38. Postmarketing surveillance. Oleen MA Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449 [TBL] [Abstract][Full Text] [Related]